Should be an interesting few weeks coming up. The phase 1 Progenza trial is coming up to completion, John Martin has stated results of this trial will be released in May. A positive result should lead to a significant re-rate. I suspect, in addition, it may trigger another milestone payment from AGC.
Ann: Appendix 3Y Change of Director's Interest Notice, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
